Sökning: id:"swepub:oai:DiVA.org:kth-323643" >
Old Enemy with a Ne...
Old Enemy with a New Face : Re-emerging Monkeypox Disease - An Update
-
- Islam, Md Aminul (författare)
- Noakhali Sci & Technol Univ, Dept Microbiol, COVID 19 Diagnost Lab, Noakhali 3814, Bangladesh.;President Abdul Hamid Med Coll, Dept Microbiol, Adv Mol Lab, Karimganj 2310, Kishoreganj, Bangladesh.
-
- Hemo, Mizbahul Karim (författare)
- Primeasia Univ, Dept Microbiol, Star Tower & HBR,Room 601,12 Kemal Ataturk Ave, Dhaka 1213, Bangladesh.
-
- Chopra, Hitesh (författare)
- Chitkara Univ, Chitkara Coll Pharm, Rajpura 140401, India.
-
visa fler...
-
- Amin, Mohammad Ruhul (författare)
- Noakhali Sci & Technol Univ, Dept Microbiol, COVID 19 Diagnost Lab, Noakhali 3814, Bangladesh.
-
- Bhattacharya, Prosun, 1962- (författare)
- KTH,Hållbar utveckling, miljövetenskap och teknik,COVID 19 Res.
-
- Dhama, Kuldeep (författare)
- ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India.
-
visa färre...
-
Noakhali Sci & Technol Univ, Dept Microbiol, COVID 19 Diagnost Lab, Noakhali 3814, Bangladesh;President Abdul Hamid Med Coll, Dept Microbiol, Adv Mol Lab, Karimganj 2310, Kishoreganj, Bangladesh. Primeasia Univ, Dept Microbiol, Star Tower & HBR,Room 601,12 Kemal Ataturk Ave, Dhaka 1213, Bangladesh. (creator_code:org_t)
- DR M N KHAN, 2022
- 2022
- Engelska.
-
Ingår i: JOURNAL OF PURE AND APPLIED MICROBIOLOGY. - : DR M N KHAN. - 0973-7510. ; 16, s. 2972-2988
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- Human monkeypox (MPX), a multi-country re-emerging disease, is rapidly spreading around the world. The etiological agent of this disease, Monkeypox virus (MPXV), is a DNA virus classified into three genetic types (West Africa, Congo Basin clade, and one new clade-3). Atypical or unusual symptoms as well as asymptomatic infection of MPXV has also been reported. Transmission among humans is possible by droplets, contact, sexual intercourse, and fomites. Secondary transmission of this disease has been reported to occur in less than 10% of cases where it was found 35%-88% of smallpox. Mother-to-fetus transmission by vertical route is also possible for this disease. Modern equipment, biosafety level-3 laboratory facilities, and trained expert persons are needed to diagnose this disease. Previous data support that similar to 85% clinical protection is provided by smallpox vaccines for monkeypox, although initially non-human primates models were used for various experiments, and also side-effects of this vaccine have been notably mentioned in various studies. Limited research findings of JYNNEOS vaccine has supported the comparatively lower prevalence of MPX cases with vaccination. Few drugs, including cidofovir, tecovirimat, brincidofovir, and vaccinia immune globulin intravenous are preferable against this disease, although clinical trial data is limited and FDA-approval is also pending. This review-based study presents an overall scenario of Monkeypox disease (MPXD) based on previously published studies. Recommended clinical treatment and vaccination, appropriate infection prevention and control strategies, adopting one health approach, and quick identification of hotspots using a wastewater-based surveillance system need to be followed to check the further spread of MPX outbreaks.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- Monkeypox (MPX)
- Monkeypox Virus (MPXV)
- Epidemiology
- Virology
- Prevention and Control
- Treatment
- Vaccine
- JYNNEOS Vaccine
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas